The given bar chart compares and contrasts the total sales of drug company in 4 regions namely Asia, European and Africa, North America and South America, measured in percentage in the period of 5 years consecutive from 2002 to 2006. A sweeping overview, European and Africa regions always reached the highest percentage in this timeframe while South America always stayed at the lowest position.
In 5 years, Asia region sales had fluctuation, starting at 12% in 2002, this figure raised to 20% in 2003, which was 8% increase within one year. It continued to increase, which had 22% and 24% in 2004 and 2006 respectively, which was approximately 10% higher than at the beginning. At the final year of the timeframe, it accounted for 28% and was 14% higher than in 2002. Whereas sales in European and Afica regions exhibited stability, starting at 44% in 2002, it raised a minor percentage to 45% in 2003, followed by 48% in 2006. After increasing, this figure declined to 44% and 40% in 2005 and 2006 respectively.
The sales of American in two regions North and South have differences. The North America accounted for 33% in 2002, followed by a decrease in 2003 with 28%. It continued to decrease to 24% and 21% in 2004 and 2005. This figure 21% which exhibited stability until the end of the timeframe in 2006. Whereas, South American stayed a minor percentage. There was the same figure at 11% in 3 years, which was 2002, 2005 and 2006. While the other 2 years was lower than 11%, in 2003 it accounted for 7% and stayed at 6% in 2004.